LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 Linsitinib
0.12
uM
LJP5
0.9165 0.0157 0.9003 0.0187
BT-20 Linsitinib
0.37
uM
LJP5
0.9552 0.0343 0.9489 0.0407
BT-20 Linsitinib
1.11
uM
LJP5
0.9348 0.0269 0.9239 0.0310
BT-20 Linsitinib
3.33
uM
LJP5
0.9114 0.0251 0.8955 0.0289
BT-20 Linsitinib
10
uM
LJP5
0.8312 0.0264 0.7966 0.0292
BT-20 Ruxolitinib
0.04
uM
LJP5
0.9752 0.0321 0.9727 0.0382
BT-20 Ruxolitinib
0.12
uM
LJP5
0.9497 0.0104 0.9416 0.0109
BT-20 Ruxolitinib
0.37
uM
LJP5
0.9563 0.0227 0.9501 0.0264
BT-20 Ruxolitinib
1.11
uM
LJP5
0.9782 0.0402 0.9730 0.0461
BT-20 Ruxolitinib
3.33
uM
LJP5
0.9440 0.0427 0.9330 0.0500
BT-20 Ruxolitinib
10
uM
LJP5
0.7635 0.0306 0.7073 0.0428
BT-20 Momelotinib
0.04
uM
LJP5
0.9373 0.0349 0.9261 0.0414
BT-20 Momelotinib
0.12
uM
LJP5
0.8920 0.0198 0.8711 0.0222
BT-20 Momelotinib
0.37
uM
LJP5
0.8649 0.0400 0.8372 0.0477
BT-20 Momelotinib
1.11
uM
LJP5
0.7929 0.0250 0.7475 0.0267
BT-20 Momelotinib
3.33
uM
LJP5
0.6635 0.0399 0.5757 0.0422
BT-20 Momelotinib
10
uM
LJP5
0.3397 0.0348 0.0633 0.0595
BT-20 Fedratinib
0.04
uM
LJP5
1.0373 0.0158 1.0423 0.0168
BT-20 Fedratinib
0.12
uM
LJP5
0.9741 0.0046 0.9693 0.0056
BT-20 Fedratinib
0.37
uM
LJP5
0.9433 0.0126 0.9341 0.0128
BT-20 Fedratinib
1.11
uM
LJP5
0.8520 0.0188 0.8229 0.0176
BT-20 Fedratinib
3.33
uM
LJP5
0.7028 0.0194 0.6294 0.0138
BT-20 Fedratinib
10
uM
LJP5
0.2367 0.0342 -0.1411 0.0802
BT-20 Trametinib
0.04
uM
LJP5
0.7653 0.0212 0.7101 0.0267
BT-20 Trametinib
0.12
uM
LJP5
0.8178 0.0274 0.7802 0.0280